Document is current
Any future updates will be listed below
-
Authors
Leonard, Fransisca
Curtis, Louis T.
Hamed, Ahmed R.
Zhang, Carolyn
Chau, Eric
Sieving, Devon
Godin, Biana
Frieboes, Hermann B. https://orcid.org/0000-0001-5959-4286
-
Funding
Funding for this research was provided by:
Dr. Cyrus and Myrtle Katzen Cancer Research Center, George Washington University (Cardiovascular Nanomedicine Grant)
Houston Methodist Research Institute (Department of Nanomedicine Innovative Grant Award, METAvivor Foundation Early Career Investigator Award)
National Cancer Institute (R15CA203605)
- License Information
-
More Information
Article History
Received: 21 June 2019
Accepted: 24 January 2020
First Online: 8 February 2020
Compliance with ethical standards
:
: The authors have no conflicts to disclose.
: In vivo mouse studies were performed in accordance with the Houston Methodist Research Institute Institutional Animal Care and Use Committee (IACUC—approval number: AUP-0617–0020). The animal research was conducted in full compliance with federal, state, and local regulations and institutional policies.
: Balb/c mice (6–8 weeks, females) were purchased from Jackson laboratory for all of the animal experiments in this study.
: 4T1 mouse breast cancer cells were purchased from the American Type Culture Collection (ATCC) (Manassas, VA, USA), which tests and authenticates the cells in its collection.
